BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.180
-0.025 (-2.07%)
At close: Mar 6, 2026, 4:00 PM EST
1.180
0.00 (-0.01%)
After-hours: Mar 6, 2026, 7:58 PM EST

BioCardia Revenue

In the year 2024, BioCardia had annual revenue of $58.00K, down -87.84%.

Revenue (ttm)
$58.00K
Revenue Growth
-87.84%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
12.52M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202458.00K-419.00K-87.84%
Dec 31, 2023477.00K-875.00K-64.72%
Dec 31, 20221.35M337.00K33.20%
Dec 31, 20211.02M870.00K600.00%
Dec 31, 2020145.00K-565.00K-79.58%
Dec 31, 2019710.00K85.00K13.60%
Dec 31, 2018625.00K146.00K30.48%
Dec 31, 2017479.00K-97.00K-16.84%
Dec 31, 2016576.00K-328.00K-36.28%
Dec 31, 2015904.00K477.00K111.71%
Dec 31, 2014427.00K159.00K59.33%
Dec 31, 2013268.00K206.00K332.26%
Dec 31, 201262.00K50.00K416.67%
Dec 31, 201112.00K--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 20081.27M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioLineRx12.74M
BioAtla11.00M
Traws Pharma2.85M
CytoMed Therapeutics573.19K
Can-Fite BioPharma560.00K
Soligenix2.34K
Revenue Rankings